Who are Montis Biosciences's investors?

Montis Biosciences's investors include ALSA Ventures, Droia Ventures, Pfizer Ventures, VIB, Pfizer Venture Investments.

Where is Montis Biosciences headquartered?

Montis Biosciences is headquartered in Leuven, BE.

Montis Biosciences

Leuven, BE · 6 known investors

Find your way into Montis Biosciences

Paths you didn't know you had: your email and LinkedIn already hold routes to the Montis Biosciences team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Montis Biosciences is a biotechnology company developing anti-C1q antibodies that target both the complement and myeloid axes to treat neuroinflammatory, autoimmune, neurodegenerative and ophthalmic diseases, with a lead program in Guillain-Barré syndrome. It also has a second program inhibiting CD93 for lung squamous cell carcinoma.

Biotech Healthtech

Founders & leadership

Federico GrossiClinical Advisor & Acting CMO

Investors · 6

ALSA Ventures✓ confirmed by Montis BiosciencesLondon

How we know: the company's own site · biospace.com · Not right? Tell us

Droia Ventures✓ confirmed by Montis BiosciencesLuxembourg · $540K

How we know: the company's own site · biospace.com · droiaventures.com · Not right? Tell us

Pfizer Ventures✓ confirmed by Montis Biosciences

How we know: the company's own site · biospace.com · Not right? Tell us

VIB✓ confirmed by Montis BiosciencesGhent

How we know: the company's own site · Not right? Tell us

Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M

How we know: the VCSheet dataset · Not right? Tell us

Also in the syndicate · 1

Polaris Partners

Funding

SEC filings, press & company announcements

Undisclosed amountseed financingFeb 2020
ALSA Ventures, Droia Ventures, Pfizer Ventures, Polaris Partners
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Montis Biosciences Awarded VLAIO Grant to Expand its Pipeline of Novel Immune-Oncology Therapeutics – Droia Ventures – Investing in Impactdroiaventures.com · Jun 2021

Montis Biosciences launched with €8,4 million seed financing and a novel approach to immuno-oncology - BioSpacebiospace.com · Feb 2020

Frequently asked questions

What does Montis Biosciences do?: Montis Biosciences is a biotechnology company developing anti-C1q antibodies that target both the complement and myeloid axes to treat neuroinflammatory, autoimmune, neurodegenerative and ophthalmic diseases, with a lead program in Guillain-Barré syndrome. It also has a second program inhibiting CD93 for lung squamous cell carcinoma.
Who are Montis Biosciences's investors?: Montis Biosciences's investors include ALSA Ventures, Droia Ventures, Pfizer Ventures, VIB, Pfizer Venture Investments.
Where is Montis Biosciences headquartered?: Montis Biosciences is headquartered in Leuven, BE.